Calvete J J, Schäfer W, Mann K, Henschen A, González-Rodríguez J
Instituto de Química Física, C. S. I. C., Madrid, Spain.
Eur J Biochem. 1992 Jun 15;206(3):759-65. doi: 10.1111/j.1432-1033.1992.tb16982.x.
The non-covalent and Ca(2+)-dependent heterodimer GPIIb/IIIa, formed by platelet glycoproteins IIb (GPIIb) and IIIa (GPIIIa), also known as the integrin alpha IIb beta 3, is the inducible receptor for fibrinogen and other adhesive proteins on the surface of activated platelets. A fraction of the isolated GPIIb/IIIa in solution binds RGD or KQAGDV inhibitory peptides and, upon peptide removal, apparently acquires the capacity to bind fibrinogen ('activated' GPIIb/IIIa) [Du, X., Plow, E. F., Frelinger, A. L., III, O'Toole, T. E., Loftus, J. C. & Ginsberg, M. H. (1991) Cell 65, 409-416]. Photoaffinity labelling was used here to study the ligand binding site(s) of GPIIb/IIIa in solution, for which the peptides CKRKRKRKRRGDV (alpha 1), CGRGDF (alpha 2), CYHHLGGAKQAGDV (gamma 1) and CGAKQAGDV (gamma 2) were synthesized with a photoactivable cross-linker group and a fluorescent reporter group attached to the N-terminal cysteine residue. Contrary to the situation in activated platelets, both GPIIb and GPIIIa were equally labelled by the four peptides and the cross-linking sites were localized by protein chemical analyses of the fluorescently labelled tryptic peptides of both subunits. Thus, the localization of the cross-linking sites in GPIIb varies considerably with the peptide length and is very different from that localization observed in activated platelets: alpha 2 and gamma 2 were found cross-linked to the N-terminal of both the heavy (GPIIbH 42-73) and the light (GPIIbL2 30-75) chains of GPIIb; while the longer peptides alpha 1 and gamma 1 were cross-linked to the C-terminal of GPIIbH within the 696-724 and 752-768 peptide stretches, respectively. On the other hand, the cross-linking sites of the four inhibitory peptides in GPIIIa were found mainly within the proteolysis susceptible region, between the N-terminal (GPIIIa 1-52) and the core (GPIIb 423-622) highly disulphide-bonded domains, observing that the longer the peptide the closer the cross-linking site is to the N-terminal of GPIIIa: alpha 1 at GPIIIa 63-87 and 303-350; gamma 1 at GPIIIa 9-37; alpha 2 at GPIIIa 151-191; and gamma 2 at GPIIIa 303-350. These results led us to the following conclusions. (a) The GPIIIa 100-400 region contributes to the ligand-binding domain in GPIIb/IIIa both in solution and in activated platelets.(ABSTRACT TRUNCATED AT 400 WORDS)
由血小板糖蛋白IIb(GPIIb)和IIIa(GPIIIa)形成的非共价且依赖钙离子的异二聚体GPIIb/IIIa,也被称为整联蛋白αIIbβ3,是活化血小板表面纤维蛋白原和其他黏附蛋白的诱导型受体。溶液中分离出的一部分GPIIb/IIIa能结合RGD或KQAGDV抑制性肽段,去除肽段后,它显然获得了结合纤维蛋白原的能力(“活化的”GPIIb/IIIa)[Du, X., Plow, E. F., Frelinger, A. L., III, O'Toole, T. E., Loftus, J. C. & Ginsberg, M. H. (1991) Cell 65, 409 - 416]。本文采用光亲和标记法研究溶液中GPIIb/IIIa的配体结合位点,为此合成了肽段CKRKRKRKRRGDV(α1)、CGRGDF(α2)、CYHHLGGAKQAGDV(γ1)和CGAKQAGDV(γ2),它们在N端半胱氨酸残基上连接了可光活化的交联基团和荧光报告基团。与活化血小板中的情况相反,这四种肽段对GPIIb和GPIIIa的标记程度相同,通过对两个亚基的荧光标记胰蛋白酶肽段进行蛋白质化学分析来确定交联位点。因此,GPIIb中交联位点的定位随肽段长度变化很大,与活化血小板中观察到的定位非常不同:发现α2和γ2与GPIIb重链(GPIIbH 42 - 73)和轻链(GPIIbL2 30 - 75)的N端交联;而较长的肽段α1和γ1分别与GPIIbH的C端在696 - 724和752 - 768肽段区域交联。另一方面,发现这四种抑制性肽段在GPIIIa中的交联位点主要在N端(GPIIIa 1 - 52)和核心(GPIIb 423 - 622)高度二硫键连接结构域之间的蛋白水解敏感区域内,观察到肽段越长,交联位点越靠近GPIIIa的N端:α1在GPIIIa 63 - 87和303 - 350;γ1在GPIIIa 9 - 37;α2在GPIIIa 151 - 191;γ2在GPIIIa 303 - 350。这些结果使我们得出以下结论。(a)GPIIIa的100 - 400区域在溶液中和活化血小板中均对GPIIb/IIIa的配体结合结构域有贡献。(摘要截断于400字)